Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
32.15
+0.05 (0.16%)
Apr 17, 2026, 1:30 PM CST

Sinphar Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,1155,8015,6525,6945,5604,847
Market Cap Growth
5.16%2.64%-0.75%2.41%14.71%-6.62%
Enterprise Value
6,9016,7366,5966,8806,6346,118
Last Close Price
32.1530.5028.8028.2426.7623.16
PE Ratio
16.7415.8618.5515.1824.75-
Forward PE
-21.4821.4821.4821.4821.48
PS Ratio
1.811.721.791.921.951.99
PB Ratio
1.651.561.591.681.731.58
P/TBV Ratio
1.811.711.771.881.961.86
P/FCF Ratio
15.6814.8816.016621.1219.59-
P/OCF Ratio
10.469.929.5219.2113.0735.76
EV/Sales Ratio
2.052.002.092.322.322.51
EV/EBITDA Ratio
10.4410.2012.2213.2814.8595.71
EV/EBIT Ratio
16.4616.0622.2023.8333.40-
EV/FCF Ratio
17.7017.2718.687999.4723.38-
Debt / Equity Ratio
0.410.410.540.570.600.69
Debt / EBITDA Ratio
2.282.283.523.754.2833.06
Debt / FCF Ratio
3.873.875.392261.466.74-
Net Debt / Equity Ratio
0.140.140.200.250.210.29
Net Debt / EBITDA Ratio
0.780.781.341.671.5013.91
Net Debt / FCF Ratio
1.321.322.051004.312.36-83.59
Asset Turnover
0.540.540.500.480.460.39
Inventory Turnover
2.532.532.352.222.171.86
Quick Ratio
1.721.721.301.461.361.22
Current Ratio
2.502.501.842.201.921.76
Return on Equity (ROE)
9.76%9.76%8.21%10.79%5.22%-6.59%
Return on Assets (ROA)
4.21%4.21%2.96%2.90%2.00%-1.85%
Return on Invested Capital (ROIC)
8.73%8.71%6.47%7.09%3.39%-4.53%
Return on Capital Employed (ROCE)
8.20%8.20%6.10%5.70%4.20%-3.90%
Earnings Yield
5.98%6.30%5.39%6.59%4.04%-0.79%
FCF Yield
6.38%6.72%6.25%0.01%5.10%-0.22%
Dividend Yield
3.11%3.28%3.31%3.12%3.30%0.76%
Payout Ratio
49.53%49.53%55.04%44.71%14.93%-
Buyback Yield / Dilution
-0.05%-0.05%-0.01%0.00%-0.17%-
Total Shareholder Return
3.06%3.23%3.29%3.13%3.12%0.76%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.